Our impact

With your support, we:

4 strategies for embracing vitiligo & the summer

As I write this, I am sitting in my garden topped up with factor 50 whilst enjoying the warm August weather. We’ve had some pretty hot days on record in the UK and it’s nice to be able to enjoy these moments and see the sun more like a friend than a foe, like I […]

27 August 2024

Read more

INTERCEPT Study participants required

INTERnational Consensus on definition of SEverity and relaPse in viTiligo The research team from the Walsall Healthcare & The Royal Wolverhampton NHS Trusts and the University of Birmingham are seeking participants to take part in the INTERCEPT research study. What is the purpose of this research study? The study invites you to share your views […]

3 September 2024

Read more

Anifrolumab: Investigating a new approach for vitiligo treatment

Amidst ongoing research for more effective treatments, Anifrolumab—a drug developed by AstraZeneca—is currently undergoing Phase II clinical trials to evaluate its potential in treating this complex skin condition. Understanding Anifrolumab Anifrolumab is a monoclonal antibody, a type of drug designed to act on specific components within the body’s immune system. It specifically targets IFN-alpha receptor-1 […]

27 August 2024

Read more

From Fixed to Growth: How changing my mindset helped me to love my skin

Developing vitiligo at such a young age (I was three years old) profoundly shaped my outlook on life and altered my perception of beauty as I became acutely aware that I was different. There were plenty of times when I felt isolated during my teen years; my skin creating a distinct separation between me and […]

27 August 2024

Read more